Phase II trial of neoadjuvant docetaxel and gefitinib followed by radical prostatectomy in patients with high-risk, locally advanced prostate cancer
2009 ◽
Vol 115
(4)
◽
pp. 784-791
◽
Jacqueline Vuky
◽
Christopher Porter
◽
Christina Isacson
◽
Matthew Vaughan
◽
Paul Kozlowski
◽
...
2004 ◽
Vol 22
(14_suppl)
◽
pp. 4753-4753
◽
M. Q. Baggstrom
◽
J. Rosenman
◽
R. Pruthi
◽
Y. Whang
◽
L. Goyal
◽
...
2004 ◽
Vol 22
(14_suppl)
◽
pp. 4753-4753
M. Q. Baggstrom
◽
J. Rosenman
◽
R. Pruthi
◽
Y. Whang
◽
L. Goyal
◽
...
2004 ◽
Vol 63
(6)
◽
pp. 1138-1142
◽
Robert Dreicer
◽
Cristina Magi-Galluzzi
◽
Ming Zhou
◽
Jason Rothaermel
◽
Alwyn Reuther
◽
...
2001 ◽
Vol 57
(2)
◽
pp. 281-285
◽
Peter E Clark
◽
David M Peereboom
◽
Robert Dreicer
◽
Howard S Levin
◽
Sarah B Clark
◽
...
2004 ◽
Vol 171
(4S)
◽
pp. 280-280
Eric A. Klein
◽
Robert Dreicer
◽
Cristina Magi-Galluzzi
◽
Ming Zhou
◽
Craig D. Zippe
◽
...
Fabio Zattoni
◽
Alessandro Morlacco
◽
Fabio Matrone
◽
Mauro Arcicasa
◽
Lorenzo Buttazzi
◽
...
2006 ◽
Vol 107
(2)
◽
pp. 389-395
◽
Nicholas Bruchovsky
◽
Laurence Klotz
◽
Juanita Crook
◽
Shawn Malone
◽
Charles Ludgate
◽
...
2017 ◽
Vol 16
(3)
◽
pp. e1673
J.Y. Joung
◽
S.H. Kim
◽
H.K. Seo
◽
J. Chung
◽
K.H. Cho
◽
...